169 related articles for article (PubMed ID: 25923153)
1. Anterior apical cores in the initial prostate biopsy does not increase detection of significant prostate cancer.
Ekin RG; Zorlu F; Akarken I; Yildirim Z; Tarhan H; Koc G; Kucuk U; Bayol U
Urol J; 2015 Apr; 12(2):2084-9. PubMed ID: 25923153
[TBL] [Abstract][Full Text] [Related]
2. The eternal enigma in prostatic biopsy access route.
Fabiani A; Principi E; Filosa A; Servi L
Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and morbidity of transrectal ultrasound-guided 12-core biopsy for detection of prostate cancer in Japanese men.
Matsumoto K; Satoh T; Egawa S; Shimura S; Kuwao S; Baba S
Int J Urol; 2005 Apr; 12(4):353-60. PubMed ID: 15948721
[TBL] [Abstract][Full Text] [Related]
4. Low risk patients benefit from extreme anterior apical sampling on initial biopsy for prostate cancer diagnosis.
Elshafei A; Kartha G; Li Y; S Moussa A; Hatem A; Gao T; Jones JS
Prostate; 2014 Sep; 74(12):1183-8. PubMed ID: 24962004
[TBL] [Abstract][Full Text] [Related]
5. Detection rate of anterior prostate cancer in 226 patients submitted to initial and repeat transperineal biopsy.
Pepe P; Dibenedetto G; Pennisi M; Fraggetta F; Colecchia M; Aragona F
Urol Int; 2014; 93(2):189-92. PubMed ID: 24776888
[TBL] [Abstract][Full Text] [Related]
6. Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
Pepe P; Pennisi M; Fraggetta F
Int Braz J Urol; 2015; 41(5):844-8. PubMed ID: 26689509
[TBL] [Abstract][Full Text] [Related]
7. Importance of additional "extreme" anterior apical needle biopsies in the initial detection of prostate cancer.
Moussa AS; Meshref A; Schoenfield L; Masoud A; Abdel-Rahman S; Li J; Flazoura S; Magi-Galluzzi C; Fergany A; Fareed K; Jones JS
Urology; 2010 May; 75(5):1034-9. PubMed ID: 20080294
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of initial transperineal 14-core prostate biopsy to detect significant cancer.
Takeshita H; Numao N; Kijima T; Yokoyama M; Ishioka J; Matsuoka Y; Koga F; Saito K; Masuda H; Kawakami S; Yamamoto S; Yonese J; Fujii Y; Kihara K
Int Urol Nephrol; 2013 Jun; 45(3):645-52. PubMed ID: 23529272
[TBL] [Abstract][Full Text] [Related]
9. Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care.
Ukimura O; Coleman JA; de la Taille A; Emberton M; Epstein JI; Freedland SJ; Giannarini G; Kibel AS; Montironi R; Ploussard G; Roobol MJ; Scattoni V; Jones JS
Eur Urol; 2013 Feb; 63(2):214-30. PubMed ID: 23021971
[TBL] [Abstract][Full Text] [Related]
10. Prostate biopsy: results and advantages of the transperineal approach--twenty-year experience of a single center.
Pepe P; Aragona F
World J Urol; 2014 Apr; 32(2):373-7. PubMed ID: 23743734
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of transrectal ultrasound-guided prostate biopsy, targeting eight cores, for detecting prostate cancer in Japanese men.
Ishimura T; Sakai I; Hara I; Eto H; Miyake H
Int J Clin Oncol; 2004 Feb; 9(1):47-50. PubMed ID: 15162826
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging targeted biopsy in men with previously negative prostate biopsy results.
Lee SH; Chung MS; Kim JH; Oh YT; Rha KH; Chung BH
J Endourol; 2012 Jul; 26(7):787-91. PubMed ID: 22122555
[TBL] [Abstract][Full Text] [Related]
14. Length of prostate biopsy cores: does it impact cancer detection?
Fiset PO; Aprikian A; Brimo F
Can J Urol; 2013 Aug; 20(4):6848-53. PubMed ID: 23930611
[TBL] [Abstract][Full Text] [Related]
15. Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of <10.0 ng/mL in real-world practice.
Oh KT; Koo KC; Chung BH; Lee KS
Investig Clin Urol; 2020 Jan; 61(1):28-34. PubMed ID: 31942460
[TBL] [Abstract][Full Text] [Related]
16. How many cores should be taken in a repeat biopsy on patients in whom atypical small acinar proliferation has been identified in an initial transrectal prostate biopsy?
Aglamis E; Kocaarslan R; Yucetas U; Toktas G; Ceylan C; Doluoglu OG; Unluer E
Int Braz J Urol; 2014; 40(5):605-12. PubMed ID: 25498271
[TBL] [Abstract][Full Text] [Related]
17. Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?
Schimmöller L; Quentin M; Blondin D; Dietzel F; Hiester A; Schleich C; Thomas C; Rabenalt R; Gabbert HE; Albers P; Antoch G; Arsov C
Eur Radiol; 2016 Nov; 26(11):3858-3864. PubMed ID: 26920391
[TBL] [Abstract][Full Text] [Related]
18. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
19. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
